All chi-med articles
-
Business
Landmark China cancer drug full approval ‘first of a wave’
Chi-Med’s fruquintinib is a result of China’s evolving drug innovation and regulation
Chi-Med’s fruquintinib is a result of China’s evolving drug innovation and regulation